GENEVA, Nov. 5 -- SPARK THERAPEUTICS, INC. (3737 Market Street, Suite 1300Philadelphia, PA 19104) filed a patent application (PCT/US2025/026098) for "NUCLEIC ACID ENCODING IDES" on Apr 24, 2025. With publication no. WO/2025/226891, the details related to the patent application was published on Oct 30, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MOURA, Pedro (c/o Spark Therapeutics, Inc.3737 Market Street, Suite 1300Philadelphia, PA 19104), YAZICIOGLU, Mustafa (c/o Spark Therapeutics, Inc.3737 Market Street, Suite 1300Philadelphia, PA 19104)
Abstract: The present invention includes nucle...